T1	Participants 471 644	patients who participated in the STOPD-PD study, a randomized, double-blind, clinical trial comparing a combination of olanzapine plus sertraline vs. olanzapine plus placebo
T2	Participants 910 1044	subjects with a history of no prior treatment or inadequate treatment who were treated with a combination of olanzapine and sertraline
T3	Participants 1083 1204	subjects who had previously failed to respond to an antidepressant alone and who were treated with olanzapine monotherapy
T4	Participants 1248 1352	subjects who had previously failed to respond to a combination of an antipsychotic and an antidepressant
T5	Participants 1482 1501	patients with MDpsy
T6	Participants 325 373	major depression with psychotic features (MDpsy)
